HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NTP peer review

This article was originally published in The Rose Sheet

Executive Summary

The National Toxicology Program Board of Scientific Counselors Technical Reports Review Subcommittee will meet Aug. 28 to discuss peer review findings and conclusions presented in five draft NTP technical reports of rodent toxicology and carcinogenicity studies in genetically modified mice, National Institutes of Environmental Health Sciences announces in July 10 Federal Register 1notice. The meeting will begin at 8:30 a.m. at NIEHS in Research Triangle Park, N.C. Technical reports slated for review include document on benzene, which is used in the manufacture of dyes, oils, varnishes and lacquers. Subcommittee most recently met June 12 to review four technical reports on four other ingredients (2"The Rose Sheet" March 13, 2006, In Brief)...

You may also be interested in...



NTP peer review

National Toxicology Program Board of Scientific Counselors Technical Reports Review Subcommittee will hold a meeting June 12 in Triangle Park, N.C. to review findings and conclusions from four draft NTP Technical Reports on rodent toxicology and carcinogenicity studies conducted by NTP, National Institute of Environmental Health Sciences announces in March 9 Federal Register 1notice. Technical reports include document on methylene blue trihydrate, a dye previously used in hair colorants, as well as a report on alpha-methylstyrene, used in the production of resins and polymers. Subcommittee deliberations will be reported to the NTP Board at a future date...

Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing

Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.

Parkinson’s Results Further Sweeten AbbVie’s Acquisition of Cerevel

Cerevel, which AbbVie is spending $8.7bn to acquire, unveiled topline results from the TEMPO-3 study of tavapadon, which an analyst said represents potentially a $1bn opportunity.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014076

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel